The remaining signature of increased proteins in AD was associated with nuclear metabolism (SDC4, SPOCK3, CEP63) and fatty‐acid metabolism (FABP7, TP22, and FKBP1A) (Figure 4A). This evidence concerns the gene CEP63 and Alzheimer disease.